These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22950917)

  • 1. Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor.
    Fang RH; Chen KN; Aryal S; Hu CM; Zhang K; Zhang L
    Langmuir; 2012 Oct; 28(39):13824-9. PubMed ID: 22950917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.
    Fang RH; Aryal S; Hu CM; Zhang L
    Langmuir; 2010 Nov; 26(22):16958-62. PubMed ID: 20961057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrohydrodynamic atomization for biodegradable polymeric particle production.
    Xie J; Lim LK; Phua Y; Hua J; Wang CH
    J Colloid Interface Sci; 2006 Oct; 302(1):103-12. PubMed ID: 16842810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic polymeric nanoparticles for biofilm-associated infection therapy.
    Cheow WS; Hadinoto K
    Methods Mol Biol; 2014; 1147():227-38. PubMed ID: 24664837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilized polymeric nanoparticles for controlled and efficient release of bifenthrin.
    Liu Y; Tong Z; Prud'homme RK
    Pest Manag Sci; 2008 Aug; 64(8):808-12. PubMed ID: 18366056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidics for the Production of Nanomedicines: Considerations for Polymer and Lipid-based Systems.
    Streck S; Hong L; Boyd BJ; McDowell A
    Pharm Nanotechnol; 2019; 7(6):423-443. PubMed ID: 31629401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices.
    Kim Y; Lee Chung B; Ma M; Mulder WJ; Fayad ZA; Farokhzad OC; Langer R
    Nano Lett; 2012 Jul; 12(7):3587-91. PubMed ID: 22716029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder inhaler formulation of lipid-polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles.
    Yang Y; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Sep; 434(1-2):49-58. PubMed ID: 22634138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y; Kho K; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
    Martins S; Tho I; Souto E; Ferreira D; Brandl M
    Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated polymer composite nanoparticles by rapid mixing.
    Jung C; de Roo T; Mecking S
    Macromol Rapid Commun; 2014 Dec; 35(23):2038-42. PubMed ID: 25358746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers.
    Grabnar PA; Kristl J
    J Microencapsul; 2011; 28(4):323-35. PubMed ID: 21545323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
    Mandal B; Bhattacharjee H; Mittal N; Sah H; Balabathula P; Thoma LA; Wood GC
    Nanomedicine; 2013 May; 9(4):474-91. PubMed ID: 23261500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles: continuous and potential large-scale nanoprecipitation production in static mixers.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2012 Jun; 94():68-72. PubMed ID: 22326649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general approach to synthesize asymmetric hybrid nanoparticles by interfacial reactions.
    He J; Perez MT; Zhang P; Liu Y; Babu T; Gong J; Nie Z
    J Am Chem Soc; 2012 Feb; 134(8):3639-42. PubMed ID: 22320198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.